Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, ...

How CD4+ T cells respond to Chikungunya virus may trigger long-lasting joint pain, mimicking autoimmune disease long after infection clears.

Ankylosing spondylitis causes chronic back pain and joint fusion, affecting millions. Learn the early warning signs and what ...

Patients with vitiligo experience impacts on quality of life, emerging therapies offer promising prospects for more targeted ...

While there isn't a one-size-fits-all approach to consuming bone broth, certain times of the day may be more beneficial than ...

InflaRx’s vilobelimab met the bar for futility in a Phase III trial for the rare skin disease pyoderma gangrenosum.

The reiteration comes after the company appointed the current President and COO of Roivant, Dr. Eric Venker as CEO of ...

For most children, illnesses like measles or the flu are unpleasant but manageable. A fever, a rash, some time home from ...

Experts are warning that the UK could soon be at risk of dangerous mosquito-borne viruses, with the tropical diseases set to ...

Cannabis affects the brain and body through the endocannabinoid system, influencing everything from mood to pain management ...

High-dose HCQ use may lower the risk for diabetes among patients with pSS and can potentially mitigate the diabetogenic effects of glucocorticoids.

Drugs were designed to banish discomfort and disease. But a new study has revealed that a class of common anti-inflammatory drugs may actually make people sicker. Researchers from the Norwegian ...